Unsupported Browser

We have detected that you may be using an outdated browser that is not compatible with our website.
For a better browsing experience, please upgrade to a newer browser.

Biocatalysis: Using enzymes as catalysts

19th Feb 2021

Nature’s catalysts are everywhere. From craft brewing to industrial manufacturing, these enzymes have the power to accelerate reactions of all kinds; including those in your own synthesis.

The use of enzymes as catalysts in pharmaceutical manufacturing has experienced dramatic growth over the past decade. This growth is driven, in part, by broader enzyme availability; the ability to tailor or evolve enzymes for specific syntheses, and the potential advantages that enzyme immobilisation brings to industrialisation.

But working with enzymes successfully can be a challenge. Enzymes are sensitive, they must be removed from the end product, and, enzymes and their cofactors can be expensive. Overcoming these challenges and embracing transformative advantages of biocatalysis requires the right partner.

At Sterling, we combine our years of experience in enzymatic reactions with partnerships among some of the world’s leading biocatalysis experts, to provide our clients best-in-class solutions; from enzyme screening, customisation, and immobilisation to development, scale-up, and full commercial manufacture.

Our expertise in enzyme immobilisation enables us to provide customers several compelling benefits, including greater enzyme stability, simplified separation to ensure product purity, and the ability to recycle and reuse enzymes for more sustainable and cost effective processes.

We believe in providing our customers full ownership  and enhancing our services with transparency and true scientific collaboration.

Are you ready to elevate your next biocatalysis programme with a different kind of partner?

Sterling. Service. Passion. Science.

Related Pages


Technology and Innovation Programme

Continuous | Flow

Related Content


Biocatalysis webinar


Biocatalysis whitepaper


Scientist Snapshot: Head of Technology and Innovation, Mark Muldowney